3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Breast Neoplasms
4
Prostatic Neoplasms
3
Pancreatic Neoplasms
3
Ovarian Neoplasms
3
Neoplasms
3
Urinary Bladder Neoplasms
2
Rectal Neoplasms
2
Hematologic Neoplasms
2
Colorectal Neoplasms
2
Anatomic Stage I Breast Cancer AJCC v8
2
Uterine Cervical Neoplasms
1
Triple Negative Breast Neoplasms
1
Stomatitis
1
Stomach Neoplasms
1
Sarcoma
1
Recurrence
1
Radiodermatitis
1
Papillomavirus Infections
1
Neoplasm Metastasis
1
Myelodysplastic Syndromes
1
Multiple Endocrine Neoplasia Type 1
1
Melanoma
1
Lung Neoplasms
1
Localized Prostate Carcinoma
1
Leukemia, Myeloid, Acute
1
Hepatitis B
1
Gastrointestinal Neoplasms
1
Esophageal Neoplasms
1
Endometrial Clear Cell Adenocarcinoma
1
Disease Progression
1
Interventions
Sorafenib
52
pembrolizumab
26
Nivolumab
20
Bevacizumab
19
Radiosurgery
17
Doxorubicin
12
atezolizumab
9
Erlotinib Hydrochloride
9
lenvatinib
8
cabozantinib
7
Magnetic Resonance Spectroscopy
7
tremelimumab
6
durvalumab
6
Ramucirumab
6
Radiofrequency Ablation
6
Cisplatin
6
Sunitinib
5
tislelizumab
4
regorafenib
4
Oxaliplatin
4
Leucovorin
4
Ipilimumab
4
Fluorouracil
4
Everolimus
4
Capecitabine
4
nintedanib
3
fluoromisonidazole
3
carotuximab
3
bavituximab
3
Tomography, X-Ray Computed
3
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Has results
×
Carcinoma, Hepatocellular
×
Practice Guidelines as Topic
×
Clear all
No trials found.